Tests a gentle plasma treatment for cervical HPV infection in women
Studies cold plasma treatment in adults with human papillomavirus infection of the cervix.
Plain-language title generated from the registry record
Registry title: Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Key facts
- Where
- Tübingen, GermanySee the site
Where in Germany
- University Hospital Tuebingen, Department of Women's HealthTübingen, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Tuebingen
- Trial code
- NCT06291311
- Record updated
- 30 June 2026
- Original description
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.Read full original descriptionShow less
Treatment of Infections of the Cervix Uteri With High- and Low-risk Variants of the Human Papillomavirus Using Non-invasive Physical Plasma
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
Inclusion: Inclusion criteria for NIPP treatment; Age ≥ 18 years; mRNA or DNA-based virus detection by smear (also external findings); Clearly visible transformation zone of the cervix and margins of the lesions corresponding to T1/T2; Written informed consent to participate in the study; Inclusion criteria for control group; Age ≥ 18 years; Swab-based mRNA or DNA-based virus detection (also external findings); Clearly visible transformation zone of the cervix corresponding to T1/T2; Written informed consent to participate in the study.
Exclusion: Evidence of invasive disease; Serious cardiovascular diseases; The following exclusion criteria apply to both groups of patients (NIPP treatment and control group); Transformation zone not fully visible.